Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)
China · Delayed Price · Currency is CNY 19.06
+1.20 (6.72%)
Jul 1, 2026, 3:00 PM CST
SHA:688298 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,682 | 4,527 | 5,666 | 7,209 | 12,955 | 27,660 | |
Market Cap Growth | -23.67% | -20.12% | -21.40% | -44.35% | -53.16% | 13.55% |
Enterprise Value | 1,699 | 2,322 | 2,695 | 2,201 | 5,922 | 22,133 |
Last Close Price | 19.06 | 23.43 | 29.33 | 35.76 | 61.58 | 127.17 |
PE Ratio | - | - | - | - | 6.27 | 5.62 |
Forward PE | - | 2.00 | 2.00 | 2.00 | 1.94 | 7.66 |
PS Ratio | 3.64 | 4.78 | 6.84 | 8.79 | 1.48 | 2.72 |
PB Ratio | 0.62 | 0.74 | 0.83 | 0.96 | 1.56 | 4.01 |
P/TBV Ratio | 0.73 | 0.89 | 0.95 | 1.04 | 1.69 | 4.11 |
P/FCF Ratio | - | - | - | - | 6.66 | 5.89 |
P/OCF Ratio | - | - | - | - | 4.32 | 5.32 |
EV/Sales Ratio | 1.68 | 2.45 | 3.26 | 2.68 | 0.68 | 2.18 |
EV/EBITDA Ratio | - | - | - | - | 2.53 | 3.78 |
EV/EBIT Ratio | - | - | - | - | 2.62 | 3.80 |
EV/FCF Ratio | - | - | - | - | 3.05 | 4.71 |
Debt / Equity Ratio | 0.05 | 0.05 | 0.07 | 0.08 | 0.01 | 0.00 |
Debt / EBITDA Ratio | - | - | - | - | 0.04 | 0.00 |
Debt / FCF Ratio | - | - | - | - | 0.04 | 0.00 |
Net Debt / Equity Ratio | -0.35 | -0.37 | -0.41 | -0.61 | -0.92 | -0.91 |
Net Debt / EBITDA Ratio | 8.80 | 7.32 | 4.81 | 9.06 | -3.28 | -1.07 |
Net Debt / FCF Ratio | 4.54 | 4.48 | 2.20 | 1.75 | -3.95 | -1.34 |
Asset Turnover | 0.14 | 0.12 | 0.10 | 0.08 | 0.89 | 1.62 |
Inventory Turnover | 2.01 | 1.90 | 2.01 | 1.65 | 11.43 | 6.30 |
Quick Ratio | 3.23 | 3.36 | 2.94 | 5.01 | 3.57 | 3.66 |
Current Ratio | 3.79 | 3.91 | 3.31 | 5.43 | 3.84 | 3.95 |
Return on Equity (ROE) | -9.10% | -9.28% | -7.93% | -5.27% | 27.58% | 105.79% |
Return on Assets (ROA) | -3.52% | -3.97% | -5.58% | -4.19% | 14.36% | 57.97% |
Return on Invested Capital (ROIC) | -10.64% | -12.37% | -22.02% | -36.79% | 305.18% | 1210.06% |
Return on Capital Employed (ROCE) | -6.80% | -7.70% | -11.10% | -8.30% | 26.80% | 84.10% |
Earnings Yield | -14.99% | -12.67% | -9.34% | -5.51% | 15.96% | 17.79% |
FCF Yield | -12.40% | -11.08% | -22.45% | -36.64% | 15.01% | 16.98% |
Dividend Yield | - | - | - | - | 2.71% | 2.89% |
Payout Ratio | - | - | - | - | 35.89% | 10.26% |
Buyback Yield / Dilution | 3.34% | 2.13% | 2.56% | -0.13% | 0.02% | -2.16% |
Total Shareholder Return | 3.34% | 2.13% | 2.56% | -0.13% | 2.73% | 0.73% |